N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

The Effectiveness of Group Schema Therapy in the Treatment of Borderline Symptoms in Adolescents

Sponsor: Turku University Hospital • ClinicalTrials.gov ID: NCT06606002

Registry updated: 2026-08-21
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The goal of this randomized and controlled trial is to assess the effectiveness of group schema therapy in the treatment of adolescents with borderline symptoms. The intervention utilizes self-recorded video material as an experiential method. The intervention comprises 30 group sessions and 8 individual sessions. Additionally, there are group sessions for the participants' parents. Participants in the control group receive treatment as usual.

Interventions

  • Group schema therapy (Behavioral)
    Group schema therapy based on the model by Farrell and Shaw, which is complemented with separate group sessions for the participants' parents
  • Treatment as Usual (TAU) (Behavioral)
    TAU typically comprises visits at the outpatient clinic with variable frequency and content

Eligibility criteria

Inclusion Criteria: * The participant fulfills at least three diagnostic criteria for borderline personality disorder as assessed by means of the SCID-II structured clinical interview * The participant and the participant's parent(s) are able to commit to the research protocol for the entire duration of the study * The participant is able to participate in a research intervention in Finnish and fill out the study questionnaires in Finnish Exclusion Criteria: * The participant currently has psychotic symptoms or a serious risk of suicide * The participant has been diagnosed with an intellectual disability or an autism spectrum disorder * The main clinical diagnosis of the participant is a substance abuse disorder or substance use would endanger commitment to the research intervention * The participant has another illness or symptom that endangers the participant's ability to complete the study * The participant receives some other treatment specifically aimed at borderline personality disorder symptoms

Conditions

Borderline Symptoms Borderline Personality Disorder

Locations

  • Turku University Hospital — Turku, Southwest Finland, Finland
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record